Yamaguchi, Y <br/><br/>
Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats.  [electronic resource] 

 -  Pancreas  May 1999 
 - 355-63 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0885-3177 
<br/><br/><label>Standard No.: </label>10.1097/00006676-199905000-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Ceruletide<br/>Chemokines, CXC<br/>Chemotactic Factors--blood<br/>Growth Inhibitors--blood<br/>Growth Substances--blood<br/>Hemorrhage--complications<br/>Intercellular Signaling Peptides and Proteins<br/>Isoquinolines--pharmacology<br/>Kinetics<br/>Lipopolysaccharides--pharmacology<br/>Lung--chemistry<br/>Lung Diseases--complications<br/>Macrophages, Alveolar--drug effects<br/>Male<br/>Pancreatitis--chemically induced<br/>Platelet Activating Factor--antagonists & inhibitors<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Pyridinium Compounds--pharmacology<br/>RNA, Messenger--analysis<br/>Rats<br/>Rats, Wistar<br/>Sepsis--complications<br/>Tetrahydroisoquinolines